ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Lipella Pharmaceuticals Inc

Lipella Pharmaceuticals Inc (LIPO)

2.61
0.04
(1.56%)
終了 12月22日 6:00AM
2.66
0.05
(1.92%)
取引時間後: 9:51AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
2.66
買値
2.65
売値
2.73
出来高
58,795
2.57 日の範囲 2.76
2.21 52 週間の範囲 12.00
時価総額
前日終値
2.57
始値
2.60
最終取引時間
財務取引量
US$ 156,872
VWAP
2.6681
平均取引量 (3 か月)
881,067
発行済株式数
1,208,919
配当利回り
-
PER
-0.69
1 株当たり利益 (EPS)
-3.82
歳入
450k
純利益
-4.62M

Lipella Pharmaceuticals Inc について

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic... Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Lipella Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker LIPO. The last closing price for Lipella Pharmaceuticals was US$2.57. Over the last year, Lipella Pharmaceuticals shares have traded in a share price range of US$ 2.21 to US$ 12.00.

Lipella Pharmaceuticals currently has 1,208,919 shares in issue. The market capitalisation of Lipella Pharmaceuticals is US$3.11 million. Lipella Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.69.

LIPO 最新ニュース

Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus

PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet...

Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group

PITTSBURGH, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on innovative therapies for...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.083.10077519382.582.792.53356052.63421195CS
40.249.91735537192.423.562.421631262.95779665CS
12-1.1944-30.98796180993.85444.1162.218810673.39136457CS
26-2.42-47.63779527565.08122.2122168376.13945278CS
52-5.34-66.758122.2111457596.1456873CS
156-53.5-95.263532763556.1661.762.2179124610.18968827CS
260-53.5-95.263532763556.1661.762.2179124610.18968827CS

LIPO - Frequently Asked Questions (FAQ)

What is the current Lipella Pharmaceuticals share price?
The current share price of Lipella Pharmaceuticals is US$ 2.66
How many Lipella Pharmaceuticals shares are in issue?
Lipella Pharmaceuticals has 1,208,919 shares in issue
What is the market cap of Lipella Pharmaceuticals?
The market capitalisation of Lipella Pharmaceuticals is USD 3.11M
What is the 1 year trading range for Lipella Pharmaceuticals share price?
Lipella Pharmaceuticals has traded in the range of US$ 2.21 to US$ 12.00 during the past year
What is the PE ratio of Lipella Pharmaceuticals?
The price to earnings ratio of Lipella Pharmaceuticals is -0.69
What is the cash to sales ratio of Lipella Pharmaceuticals?
The cash to sales ratio of Lipella Pharmaceuticals is 7.07
What is the reporting currency for Lipella Pharmaceuticals?
Lipella Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Lipella Pharmaceuticals?
The latest annual turnover of Lipella Pharmaceuticals is USD 450k
What is the latest annual profit for Lipella Pharmaceuticals?
The latest annual profit of Lipella Pharmaceuticals is USD -4.62M
What is the registered address of Lipella Pharmaceuticals?
The registered address for Lipella Pharmaceuticals is 108 WEST 13TH STREET, WILMINGTON, DELAWARE, 19801
What is the Lipella Pharmaceuticals website address?
The website address for Lipella Pharmaceuticals is www.lipella.com
Which industry sector does Lipella Pharmaceuticals operate in?
Lipella Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

LIPO Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock